Key findings

Treatment of postnatal depression with selective serotonin reuptake inhibitors (SSRIs) is associated with reduced risks for maternal depression and its adverse associations with the child’s behaviour and attention-deficit/hyperactivity disorder (ADHD) up to 5 years after birth. These were the main findings of a large prospective Norwegian cohort study ...